Aptinyx fibromyalgia drug misses endpoint
Biopharma company Aptinyx Inc. says its phase 2b clinical study evaluating the effects of NYX-2925…
August 15, 2022 - 2 minutes
Biopharma company Aptinyx Inc. says its phase 2b clinical study evaluating the effects of NYX-2925…